Bionano Genomics, Inc.: 10-Q filed 2018-11-07

Name: Bionano Genomics, Inc.: 10-Q filed 2018-11-07
Creator: Bionano Genomics, Inc.

What Bionano Genomics, Inc. reported in its quarterly report filed 2018-11-07 (fiscal Q3 2018): 36 published measures, 94 facts as tagged in accession 0001564590-18-028130.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-11-07
Fiscal period: fiscal Q3 2018
Accession: 0001564590-18-028130 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Bionano Genomics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-09-30	30,669,804	USD
At 2017-12-31	10,145,153	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-09-30	15,434,782	USD
At 2017-12-31	17,362,227	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2018-09-30	15,235,022	USD
At 2017-12-31	-50,227,211	USD
At 2016-12-31	-27,258,972	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-09-30	20,657,038	USD
At 2017-12-31	1,021,897	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-4,926,097	USD	92
2018-01-01 to 2018-09-30	-12,084,936	USD	273
2017-01-01 to 2017-12-31	-23,365,364	USD	365
2017-07-01 to 2017-09-30	-5,085,452	USD	92
2017-01-01 to 2017-09-30	-17,445,440	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-15,853,679	USD	273
2017-01-01 to 2017-09-30	-18,008,789	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	319,885	USD	273
2017-01-01 to 2017-09-30	736,063	USD	273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,828,704	USD	92
2018-01-01 to 2018-09-30	7,987,198	USD	273
2017-07-01 to 2017-09-30	2,743,056	USD	92
2017-01-01 to 2017-09-30	6,659,920	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	35,808,706	USD	273
2017-01-01 to 2017-09-30	16,133,264	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-319,885	USD	273
2017-01-01 to 2017-09-30	-736,063	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-09-30	-66,350,972	USD
At 2017-12-31	-54,266,036	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-2,978	USD	92
2018-01-01 to 2018-09-30	6,304	USD	273
2017-07-01 to 2017-09-30	-4,738	USD	92
2017-01-01 to 2017-09-30	17,620	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-09-30	2,049,256	USD
At 2017-12-31	3,005,788	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	160,551	USD	273
2017-01-01 to 2017-09-30	241,971	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-5,968,840	USD	92
2018-01-01 to 2018-09-30	-14,316,523	USD	273
2017-07-01 to 2017-09-30	-5,031,162	USD	92
2017-01-01 to 2017-09-30	-17,979,455	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-09-30	28,620,548	USD
At 2017-12-31	7,139,365	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	404,437	USD	92
2018-01-01 to 2018-09-30	1,114,053	USD	273
2017-07-01 to 2017-09-30	145,308	USD	92
2017-01-01 to 2017-09-30	431,403	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-09-30	5,514,646	USD
At 2017-12-31	16,652,251	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-09-30	2,363,752	USD
At 2017-12-31	2,302,964	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2018-09-30	4,000,924	USD
At 2017-12-31	3,352,214	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2018-09-30	2,614,812	USD
At 2017-12-31	1,693,742	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	3,224,075	USD	92
2018-01-01 to 2018-09-30	9,617,814	USD	273
2017-07-01 to 2017-09-30	3,116,922	USD	92
2017-01-01 to 2017-09-30	10,553,348	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,505,137	USD	92
2018-01-01 to 2018-09-30	6,962,696	USD	273
2017-07-01 to 2017-09-30	2,967,073	USD	92
2017-01-01 to 2017-09-30	9,551,687	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-09-30	10,032,687	shares
At 2017-12-31	77,257	shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2018-09-30	7,088,141	USD
At 2017-12-31	6,927,353	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2018-09-30	5,038,885	USD
At 2017-12-31	3,921,565	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-09-30	767,197	USD
At 2017-12-31	567,047	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-09-30	2,815,290	USD
At 2017-12-31	3,508,894	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-09-30	1,347,774	USD
At 2017-12-31	1,071,512	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-4,929,075	USD	92
2018-01-01 to 2018-09-30	-12,078,632	USD	273
2017-07-01 to 2017-09-30	-5,090,190	USD	92
2017-01-01 to 2017-09-30	-17,427,820	USD	273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-12,084,936	USD	273
2017-01-01 to 2017-09-30	-17,445,440	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	391,246	USD	92
2018-01-01 to 2018-09-30	1,169,801	USD	273
2017-07-01 to 2017-09-30	240,551	USD	92
2017-01-01 to 2017-09-30	964,932	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	1,039,765	USD	92
2018-01-01 to 2018-09-30	2,237,891	USD	273
2017-07-01 to 2017-09-30	-59,028	USD	92
2017-01-01 to 2017-09-30	551,635	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	386,710	USD	273
2017-01-01 to 2017-09-30	692,637	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	2,101,453	USD	273
2017-01-01 to 2017-09-30	442,849	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	60,788	USD	273
2017-01-01 to 2017-09-30	320,184	USD	273

Inspect the source

Entity: Bionano Genomics, Inc. / CIK 0001411690
Captured: 2026-09-20T08:01:58.297Z
SEC response SHA-256: de1f7683e64ca05fd1e6239a8009bb07a28d93e0115f74423aec0ba56b765b33

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411690.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))